# Foresite Capital: portfolio, investments and team > Foresite Capital is a private equity based in United States. 121 investments on record, 27 in the last 12 months, latest Sept 2026. Source: https://millionrounds.com/fund/forsite-capital (Millionrounds; every figure on the page links to its filing or article) United States · [Investor](https://millionrounds.com/investors) # Foresite Capital Last cheque observed Sep 2026; 121 cheques on record. Email Deploying now New fund $85M, Oct 2023 Private equity Website unconfirmed Seed Series A Series B Healthcare Wellness Longevity Follow Foresite Capital and see its new cheques in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Ffund%2Fforsite-capital) Deploying now **79%** of best year **27** **cheques in 12 months**, 121 on record Since the last cheque **60** days **00** hrs **00** min **00** sec Median round **$90M** Cheque size, as they say **$100K – $5.0M** Rounds led **3 of 121** Sole investor **4 rounds** Exits **2 from the portfolio** Mostly in **United States, 92%** Pitch Foresite Capital ## Foresite Capital highlights - 01 27 cheques in the last 12 months - 02 Mostly Series B and Series C: 64% of its rounds - 03 Sole investor in 4 rounds, median $78M - 04 2 exits from the portfolio ## What they do - **Type:** Private equity (from a list, unverified) - **Cheque size:** $100K – $5.0M as they say - **Stages:** Seed Series A Series B Growth Pre-IPO - **Sectors:** Healthcare Wellness Longevity - **Based in:** Larkspur, United States - **Cold pitches:** Not stated A website was listed for this organisation, but we could not confirm it belongs to the firm that wrote these cheques. Either the site never mentions them, or it turned out to be a different company sharing the name. We show neither it nor anything read from it. [Tell us the right one](https://millionrounds.com/corrections?slug=forsite-capital). ## The record Every round we can evidence, newest first **121 appearances** - **2026** 22 rounds - **Sept** **[Intellia Therapeutics](https://millionrounds.com/company/intellia-therapeutics)** Debt · US **$400M** With 3 others - **Sept** **[Tempest Therapeutics](https://millionrounds.com/company/tempest-therapeutics)** US **$2.5M** With 4 others - **Sept** **[Thyme Care](https://millionrounds.com/company/thyme-care)** Series E · US · Echo Health Ventures **$125M** With 12 others - **Sept** **[Korsana Biosciences](https://millionrounds.com/company/korsana-biosciences)** US **$380M** With 3 others - **Aug** **[Khartis Therapeutics](https://millionrounds.com/company/khartis-therapeutics)** Series B · US · Ventureburn **$50M** With 5 others - **Jun** **[Stepful](https://millionrounds.com/company/stepful)** Series C · US · Ventureburn **$55M** With 7 others - **Jun** **[ALX Oncology](https://millionrounds.com/company/alx-oncology)** Debt · US **$10M** With 4 others - **May** **[Cerevance](https://millionrounds.com/company/cerevance)** Series C · US **$20M** With 1 other - **May** **[Relay Therapeutics](https://millionrounds.com/company/relay-therapeutics)** US **$275M** With 3 others - **May** **[Pharvaris](https://millionrounds.com/company/pharvaris)** CH **$132M** With 4 others - **Apr** **[GH Research](https://millionrounds.com/company/gh-research)** IE **$118M** With 4 others - **Apr** **[ImageneBio](https://millionrounds.com/company/imagenebio)** US **$30M** With 4 others - **Mar** **[Pinnacle Medicines](https://millionrounds.com/company/pinnacle-medicines)** Series B · US **$89M** With 3 others - **Mar** **[Seaport Therapeutics](https://millionrounds.com/company/seaport-therapeutics)** Grant · US **$15M** With 2 others - **Mar** **[Solid Biosciences](https://millionrounds.com/company/solid-biosciences)** US · Firms' own news pages **$240M** With 8 others - **Feb** **[Midi Health](https://millionrounds.com/company/midi-health)** Series D · US **$100M** With 4 others - **Feb** **[Third Arc Bio](https://millionrounds.com/company/third-arc-bio)** Series A · US **$52M** With 4 others - **Feb** **[Beam Therapeutics](https://millionrounds.com/company/beam-therapeutics)** Debt · US **$100M** With 5 others - **Feb** **[Slate Medicines](https://millionrounds.com/company/slate-medicines)** Series A · US **$130M** With 2 others - **Jan** **[Vaxcyte](https://millionrounds.com/company/vaxcyte)** US **$633M** With 3 others - **Jan** **[bit.bio](https://millionrounds.com/company/bit-bio)** Series C **$50M** With 5 others - **Jan** **[Alumis](https://millionrounds.com/company/alumis)** US **$345M** With 6 others - **2025** 24 rounds - **Dec** **[Fulcrum Therapeutics](https://millionrounds.com/company/fulcrum-therapeutics)** US **$175M** With 4 others - **Dec** **[Aeovian Pharmaceuticals](https://millionrounds.com/company/aeovian-pharmaceuticals)** Series B · US **$55M** With 2 others - **Dec** **[Myome](https://millionrounds.com/company/myome)** Venture · US **Undisclosed** With 4 others - **Dec** **[Wave Life Sciences](https://millionrounds.com/company/wave-life-sciences)** US **$350M** With 4 others - **Nov** **[Invivyd](https://millionrounds.com/company/invivyd)** US **$125M** With 5 others - **Oct** **[AtaiBeckley](https://millionrounds.com/company/ataibeckley)** DE **$150M** With 4 others - **Oct** **[Tango Therapeutics](https://millionrounds.com/company/tango-therapeutics)** US **$197M** With 3 others - **Oct** **[Nurix Therapeutics](https://millionrounds.com/company/nurix-therapeutics)** US **$250M** With 5 others - **Oct** **[Rapt Therapeutics](https://millionrounds.com/company/rapt-therapeutics)** US **$250M** With 6 others - **Oct** **[Arcus Biosciences](https://millionrounds.com/company/arcus-biosciences)** US **$250M** With 3 others - **Oct** **[Indomo](https://millionrounds.com/company/indomo)** Seed · US **$25M** With 1 other - **Sept** **[Korsana Biosciences](https://millionrounds.com/company/korsana-biosciences)** Series A · US **$150M** With 5 others - **Sept** **[Avenzo Therapeutics](https://millionrounds.com/company/avenzo-therapeutics)** Series B · US **$60M** With 5 others - **Sept** **[Thyme Care](https://millionrounds.com/company/thyme-care)** Series D · US **$97M** With 3 others - **Aug** **[Mirvie](https://millionrounds.com/company/mirvie)** Venture · US **$24M** With 4 others - **Aug** **[Kriya Therapeutics](https://millionrounds.com/company/kriya-therapeutics)** Series D · US **$321M** With 2 others - **Jul** **[Quantum SI](https://millionrounds.com/company/quantum-si)** US **$50M** With 2 others - **May** **[ORIC Pharmaceuticals](https://millionrounds.com/company/oric-pharmaceuticals)** US **$125M** With 3 others An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor. ## The team Named by the firm itself, on a filing, its Form ADV or its company registration **4 named** AB **Amelia Buckley Stoj** Chief Compliance Officer and Assistant General Counsel i Form ADV DS **Dana Shonfeld Tananbaum** Trustee i Form ADV DD **Dennis Drew Ryan** Chief Financial Officer and Managing Director i Form ADV JB **James Bruce Tananbaum** Managing Member of the General Partner i Filing they signed We also hold **25** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them. ## What the register says From the firm's own filings with the SEC, which it must file accurately by law **$3.2B** assets it manages Oct 2026 **Registered** investment adviser full reporting to the SEC - **Legal name:** Foresite Capital Management, LLC - **SEC number:** CRD 162823 Funds on its Form ADV **9** private funds, **$3.5B** in gross assets · filed Mar 2024 - Foresite Capital Fund IV, L.P. *Venture* 177 investors $1.2B - Foresite Capital Fund V, L.P. *Venture* 405 investors $909M - Foresite Capital Fund VI L.P. *Venture* 314 investors $723M - Foresite Capital Opportunity Fund V, L.P. *Venture* 405 investors $233M - Foresite Capital Fund III, L.P. *Venture* 163 investors $175M - Foresite Labs Fund I, L.P. *Venture* 97 investors $154M - Foresite Capital Fund II, L.P. *Venture* 139 investors $43M - Foresite Capital VI-A, LLC *Venture* 18 investors $20M - Foresite Capital Fund I, L.P. *Venture* 70 investors $18M ## What they claim to have backed From their own portfolio page (on their website) **0** of 1 we have independently watched raise GOODLAB Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded. ## Exits from the portfolio Companies it backed that were later bought or listed **2 in all** **[Sequenta](https://millionrounds.com/company/sequenta)** Bought by Adaptive Biotechnologies **Undisclosed** Jan 2015 **[Karyopharm Therapeutics](https://millionrounds.com/company/karyopharm-therapeutics)** Listed **Undisclosed** Nov 2013 An exit counts when it came after the firm's first round in the company. From historical deal records. New fund on file **$85M** raised in Oct 2023 From its SEC filing, not a journalist: a firm that has just raised has money to deploy. ## The cheque Seed Series A Series B Median round joined **$90M** the round, not its cheque Alone, median **$78M** Led 3 of 121 rounds **2%** - **Said size:** $100K – $5.0M - **Sole investor:** 4 rounds - **Last cheque:** Sept 2026 - **Exits:** 2 from the portfolio Rounds by stage said on their site - Series B said *32* - Series C *15* - Series A said *11* - Venture *9* - Series D *7* - Seed said *-* - Growth said *-* Cheques by month Led Joined Nov 2023 Oct 2026 Often in the room with - [RA Capital Management](https://millionrounds.com/fund/ra-capital-management) 26 - [OrbiMed](https://millionrounds.com/fund/orbimed) 22 - [Cormorant Asset Management](https://millionrounds.com/fund/cormorant-asset-management) 17 - [Fidelity](https://millionrounds.com/fund/fidelity) 13 - [ARCH Venture Partners](https://millionrounds.com/fund/arch-venture-partners) 12 - [Perceptive Advisors](https://millionrounds.com/fund/perceptive-advisors) 12 **Pitching Foresite Capital?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque. Add to your CRM *→* ## Who they invest alongside The investors most often in the same rounds as Foresite Capital. A count of rooms they were both in, not a relationship either has claimed. [**RA Capital Management** Private equity **26** rounds together](https://millionrounds.com/fund/ra-capital-management)[**OrbiMed** Private equity **22** rounds together](https://millionrounds.com/fund/orbimed)[**Cormorant Asset Management** Private equity **17** rounds together](https://millionrounds.com/fund/cormorant-asset-management)[**Fidelity** VC firm **13** rounds together](https://millionrounds.com/fund/fidelity)[**ARCH Venture Partners** VC firm **12** rounds together](https://millionrounds.com/fund/arch-venture-partners)[**Perceptive Advisors** Asset manager **12** rounds together](https://millionrounds.com/fund/perceptive-advisors)[**Redmile Group** VC firm **12** rounds together](https://millionrounds.com/fund/redmile-group)[**Venrock** VC firm **11** rounds together](https://millionrounds.com/fund/venrock)[**Janus Henderson Investors** Private equity **10** rounds together](https://millionrounds.com/fund/janus-henderson-investors)[**Wellington Management** VC firm **9** rounds together](https://millionrounds.com/fund/wellington-management)[**New Enterprise Associates** VC firm **8** rounds together](https://millionrounds.com/fund/new-enterprise-associates)[**Adage Capital Management** Asset manager **7** rounds together](https://millionrounds.com/fund/adage-capital-management) ## Recently backed The latest companies Foresite Capital put money into. [**Intellia Therapeutics** $400M · Sept 2026](https://millionrounds.com/company/intellia-therapeutics)[**Tempest Therapeutics** $2.5M · Sept 2026](https://millionrounds.com/company/tempest-therapeutics)[**Thyme Care** $125M · Sept 2026](https://millionrounds.com/company/thyme-care)[**Korsana Biosciences** $380M · Sept 2026](https://millionrounds.com/company/korsana-biosciences)[**Stepful** $55M · Jun 2026](https://millionrounds.com/company/stepful)[**ALX Oncology** $10M · Jun 2026](https://millionrounds.com/company/alx-oncology) ## Mentioned on podcasts Episodes that name Foresite Capital in their description, not their title. - [The Full Ratchet](https://millionrounds.com/podcasts/full-ratchet) 16 Jul 2026 · 7 min Investor Stories 484: Why Selling Too Early Hurts Returns, The Leadership Power of Sleep, and The Costliest Investment Mistakes (Tananbaum, Ries, Demaree) Mentions [Eric Ries](https://millionrounds.com/fund/eric-ries)[Foresite Capital](https://millionrounds.com/fund/forsite-capital)[Jim Tananbaum](https://millionrounds.com/person/jim-tananbaum) Apple PodcastsShow page - [The Full Ratchet](https://millionrounds.com/podcasts/full-ratchet) 23 Apr 2026 · 4 min Investor Stories 472: Think Big, Stay Patient, Earn Access, Venture Advice from Foresite, Mayfield, and Blue Moon (Tananbaum, Chaddha, Orthlieb) Mentions [Foresite Capital](https://millionrounds.com/fund/forsite-capital)[Ben Orthlieb](https://millionrounds.com/person/ben-orthlieb-2)[Jim Tananbaum](https://millionrounds.com/person/jim-tananbaum) *+1* Apple PodcastsShow page - [The Full Ratchet](https://millionrounds.com/podcasts/full-ratchet) 19 Mar 2026 · 5 min Investor Stories 466: Jim Tananbaum, Eric Byunn, and Ben Orthlieb on the Questions LPs Should Be Asking (Tananbaum, Orthlieb, Byunn) With [Ben Orthlieb](https://millionrounds.com/person/ben-orthlieb-2)[Eric Byunn](https://millionrounds.com/person/eric-byunn)[Jim Tananbaum](https://millionrounds.com/person/jim-tananbaum) Mentions [Foresite Capital](https://millionrounds.com/fund/forsite-capital) Apple PodcastsShow page - [The Full Ratchet](https://millionrounds.com/podcasts/full-ratchet) 5 Mar 2026 · 8 min Investor Stories 463: Selling Transformation Not Software, Managing Through Activists and Mergers, and Scaling Culture with Intent (Agarwal, Tananbaum, Cohen) Mentions [David Cohen](https://millionrounds.com/fund/david-cohen)[Foresite Capital](https://millionrounds.com/fund/forsite-capital)[Techstars](https://millionrounds.com/fund/techstars) *+2* Apple PodcastsShow page - [The Full Ratchet](https://millionrounds.com/podcasts/full-ratchet) 8 Jan 2026 · 8 min Investor Stories 451: Why I Passed: Moving Too Slowly, Misreading Return Drivers, and Passing on Lyft (Banks, Tananbaum, Cohen) Mentions [David Cohen](https://millionrounds.com/fund/david-cohen)[Foresite Capital](https://millionrounds.com/fund/forsite-capital)[Techstars](https://millionrounds.com/fund/techstars) *+2* Apple PodcastsShow page ## Quick answers about Foresite Capital ### What does Foresite Capital invest in? Foresite Capital invests most often at Series B and Series C (64% of the rounds on record), in sectors such as Healthcare, Wellness and Longevity. ### How active is Foresite Capital? 121 investments on record, 27 of them in the last 12 months, and it led 3. The most recent was in Sept 2026. ### What has Foresite Capital invested in recently? Its most recent investments on record: Intellia Therapeutics (Debt, Sept 2026), Tempest Therapeutics (Undisclosed round, Sept 2026) and Thyme Care (Series E, Sept 2026). ### How big are Foresite Capital's cheques? The median round it joins is $90M. It says it writes cheques of $100K to $5.0M. ### Does Foresite Capital lead rounds? Sometimes: it led 3 of its 121 investments on record (2%). ### Where does Foresite Capital invest? Most of the companies it backs are in the United States (92%). ### Is Foresite Capital investing now? Yes: it is actively investing, with 27 investments in the last 12 months. ### Who does Foresite Capital invest alongside? Most often RA Capital Management (26 rounds together), OrbiMed (22 rounds together) and Cormorant Asset Management (17 rounds together). ## Raising now? Find the investors who back rounds like yours, and keep every conversation on one fundraising board. Find similar investorsOpen your CRM Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=forsite-capital) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=forsite-capital)